Journal of Diabetes Research / 2019 / Article / Tab 5

Research Article

Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity

Table 5

Clinical characteristics at baseline and change after 24 weeks.

CharacteristicsAt baseline, After 24 weeks, value

Body mass (kg)<0.001
BMI (kg/m2)<0.001
WC (cm)<0.001
НbA1c (%)<0.001
Glucose fasting (mmol/l)0.004
SBP (mm Hg)0.001
DBP (mm Hg)0.001
TC (mmol/l)0.215
HDL (mmol/l)1.0 (0.8; 1.3)1.1 (0.9; 1.3)0.565
LDL (mmol/l)0.189
TG (mmol/l)1.9 (1.5; 3.2)1.7 (1.4; 3.1)0.076
C-peptide fasting (ng/ml)0.569
C-peptide after test (ng/ml)0.066
НОМА-IR0.089
НОМА-β35.7 (24.5; 61.0)35.3 (27.3; 57.3)0.716

2 hours after breakfast in meal tolerance test.